&

Quintiles fills in service offerings with acquisitions

Monday, November 7, 2011 08:00 AM

Quintiles has been on an acquisitions spree. 

More... »

Synexus exceeds expectations in clinical trial recruitment

Tuesday, October 25, 2011 01:53 PM

Synexus’ Pretoria clinical research center has enrolled more patients than any other site across the world in a type 2 diabetes trial for Janssen Pharmaceuticals.

More... »

Foundation Medicine, Johnson & Johnson collaborate in oncology research

Tuesday, October 25, 2011 01:10 PM

Foundation Medicine has reported a collaboration with Johnson & Johnson Pharmaceutical Research and Development. The collaboration is focused on using Foundation Medicine's comprehensive clinical cancer genomic test to identify potential biomarkers to support J&JPRD oncology clinical development programs. Financial details of the agreement were not disclosed.

More... »

Quintiles acquires VCG, strengthening commercial services

Wednesday, October 19, 2011 01:01 PM

Quintiles has acquired VCG & Associates and VCG BIO. The addition of VCG strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

More... »

Carlyle Partners, Hellman & Friedman to acquire PPD for $3.9 billion, take the CRO private

Monday, October 10, 2011 08:02 AM

It’s official: Large equity investors Carlyle Partners and Hellman & Friedman Capital Partners are buying publicly traded PPD, taking the CRO private.

More... »

Report: U.S. medical innovation at risk without funding

Thursday, October 6, 2011 12:03 PM

U.S. venture capitalists are decreasing their investments in biopharmaceutical and medical device companies, reducing their concentration in prevalent disease areas and shifting investment away from the United States towards Europe and Asia, according to a report by the National Venture Capital Association'sMedIC Coalition.

More... »

The Carlyle Group, Hellman & Friedman to acquire PPD

Tuesday, October 4, 2011 10:42 AM

Pharmaceutical Product Development (PPD) has entered into a definitive merger agreement under which it will be acquired by affiliates of The Carlyle Group and Hellman & Friedman in an all-cash transaction valued at $3.9 billion, after which PPD will be a private company.

More... »

SIRO Clinpharm receives Indian CRO of the year award

Friday, September 30, 2011 11:37 AM

SIRO Clinpharm has been conferred with the Indian clinical research organization of the year 2011 award by Frost & Sullivan. The award was presented in Mumbai by Dr. Ajaykumar Sharma, pharmaceutical practice head, Frost & Sullivan, Middle East & India.

More... »

General Electric leads $100 million fund for breast cancer challenge

Thursday, September 15, 2011 02:03 PM

General Electric joined four venture capital firms in pledging $100 million for a six-month contest to finance ideas for improving breast cancer detection, according to Bloomberg.

More... »

Canadian government launches massive overhaul of clinical research process to create infrastructure

Monday, September 12, 2011 08:00 AM

The Canadian Institutes of Health Research (CIHR)—the federal government’s health research investment agency—is undertaking a massive overhaul of how clinical research is conducted, attempting to align large sites and other parties in all provinces to create an integrated research infrastructure.

More... »